Phenytoin pharmacokinetics in catamenial epilepsy

G. Shavit, P. Lerman, A. D. Korczyn*, S. Kivity, M. Bechar, S. Gitter

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Abstract

It is not known why the frequency of seizures sometimes increases in the perimenstrual period (catamenial epilepsy). We have examined the possibility that changes in anticonvulsant pharmacokinetics may be responsible. Seventeen women with seizures who were taking phenytoin (DPH) and whose seizures were more frequent perimenstrually were examined twice each, once on the first or second menstrual day and again after 2 weeks. Mean serum DPH levels were lower during the menses. In seven women with seizures unrelated to menses, the fall of DPH levels was much smaller. In catamenial epilepsy, the fall was due to increased DPH clearance. At the time of ovulation, hepatic DPH metabolism may be slowed by competition from steroid hormones.

Original languageEnglish
Pages (from-to)959-961
Number of pages3
JournalNeurology
Volume34
Issue number7
DOIs
StatePublished - Jul 1984

Fingerprint

Dive into the research topics of 'Phenytoin pharmacokinetics in catamenial epilepsy'. Together they form a unique fingerprint.

Cite this